Clinical Trials Logo

Filter by:
NCT ID: NCT04774250 Terminated - Clinical trials for Hearing Loss, Noise-Induced

Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)

PINIHL-AET
Start date: November 10, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of zonisamide (ZNS) for the treatment of noise-induced hearing loss in adults.

NCT ID: NCT04773197 Terminated - Cancer Clinical Trials

Evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer Patients

Start date: November 30, 2020
Phase: N/A
Study type: Interventional

This project's overall goal is to test the feasibility, acceptability and efficacy of two coach-assisted, computer-based, cognitive- behavioral therapy (C-CBT) interventions in treating depression and anxiety in adolescent and young adult cancer survivors. The two coach-assisted interventions will be compared to the standard C-CBT intervention.

NCT ID: NCT04772053 Terminated - Neoplasms Clinical Trials

Molecular Disease Characterization Initiative (MDCI)

Start date: May 25, 2021
Phase: Phase 2
Study type: Interventional

This is a single arm interventional molecular analysis study with no administration of investigational product and no masking. This multicenter study will involve participants with advanced/metastatic disease for the purpose of collecting tumor tissue and blood samples for broad molecular analysis and examining the expression of specific biomarkers using validated clinical assays.

NCT ID: NCT04770649 Terminated - Clinical trials for Vaccine Adverse Reaction

Vaccine Observation to Include All Communities for Equitable Science

VOICES
Start date: April 1, 2021
Phase:
Study type: Observational

VOICES is a longitudinal, prospective, observational study that will enroll up to 10,000 subjects of diverse racial backgrounds being administered an emergency use authorized COVID-19 vaccine, for collection and analysis of stool and blood samples. It has recently been shown that the gut microbiome, the collection of microbes that line our GI tract, play a significant role in vaccine immune response and severe complications from COVID-19. The identification of biomarkers may aid in predicting response to vaccination and are critical towards improving vaccine-induced immunity. These real-world patient derived biomarkers could be used as interventional targets for the design of innovative adjuvant co-therapies that can boost an effective immune response to the vaccine, enhancing efficacy for a broader population, including those at most risk. Subjects who meet the entry criteria will provide two samples each of blood, one prior to and one following vaccine administration. Follow-up questionnaires will be sent at 3, 6, 9, and 12 months to determine if participants have contracted COVID-19 or have experienced any adverse effects of the vaccine. Nasal swab samples will also be collected from participants that have contracted COVID-19. The samples will be analyzed to determine the impact of gut microbiome composition and function on the immune system and vaccine efficacy.

NCT ID: NCT04770402 Terminated - Clinical trials for Chemotherapy-induced Peripheral Neuropathy

Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients

Start date: September 15, 2021
Phase: N/A
Study type: Interventional

This randomized, controlled trial is designed to evaluate the effect of acupuncture on Chemotherapy-Induced Peripheral Neuropathy (CIPN), other symptoms, and potential opioid and concomitant medication sparing effects in comparison to standard of care management in Multiple Myeloma subjects.

NCT ID: NCT04770246 Terminated - Clinical trials for Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations

TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations

Start date: March 31, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of TAS-117 in patients with advanced or metastatic solid tumors (excluding primary brain tumors) harboring germline PTEN inactivating mutations.

NCT ID: NCT04770155 Terminated - Vascular Function Clinical Trials

Vascular Dysfunction in Black Individuals: Roles of Nitric Oxide and Endothelin-1

UMMC_Pilot
Start date: May 27, 2021
Phase: Early Phase 1
Study type: Interventional

The research aims of this proposal are: - Specific Aim 1: To test whether an increase in nitric oxide signaling can increase vasodilator responses in young Black individuals. - Specific Aim 2: To test whether a decrease in endothelin-1 signaling can increase vasodilator responses in young Black individuals.

NCT ID: NCT04769453 Terminated - Clinical trials for Primary Open Angle Glaucoma

Multicenter Ab-interno Glaucoma Study Investigating Canaloplasty

MAGIC
Start date: April 29, 2021
Phase: N/A
Study type: Interventional

A prospective, multicenter, randomized, single-masked clinical trial to evaluate the effectiveness outcomes of canaloplasty performed as a standalone procedure with the iTrack microcatheter to the Omni surgical system, and to compare the effectiveness of two types of Ophthalmic Viscoelastic Device (OVD).

NCT ID: NCT04768634 Terminated - Clinical trials for Congenital Heart Disease

Predicting Arrhythmogenic Risk in Congenital Heart Patients: the PRECISION Study

Start date: March 23, 2021
Phase: N/A
Study type: Interventional

In this research study we want to learn more about abnormal heart rhythm after cardiac surgery in children. These abnormal heart rhythms, also called arrhythmias, may occur due to several reasons after cardiac surgery. They can be due to abnormal electrical pathway or an irritable area of the heart that stimulates abnormal impulses. Regardless of the cause, arrhythmias after cardiac surgery can be a problem, extending the hospital stay, requiring additional medications and even leading to cardiac arrest. Current practice is to monitor for arrhythmias after cardiac surgery, and to treat them if they occur. With this research, we want to investigate whether we can identify patients who will develop arrhythmia, and treat them before they occur.

NCT ID: NCT04768569 Terminated - Clinical trials for Hearing Loss, Noise-Induced

Noise-Induced Hearing Loss-Acute Exposure Treatment

PINIHL-AET
Start date: October 4, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of zonisamide for the treatment of noise-induced hearing loss in adults.